Clinical Trial Update: Autoimmunity-blocking Antibody for Tolerance in Recently Diagnosed Type 1 Diabetes [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating an autoimmunity-blocking antibody for tolerance in recently diagnosed Type 1 diabetes has completed, with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Autoimmunity-blocking antibody for tolerance

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Diabetes Mellitus, Type 1 | Phase 2 | Status: COMPLETED | Results posted: 2013-09-16